Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-6522

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 50090-6522). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500906522)

Rosuvastatin 20 mg film-coated tablets packaging label from A-S Medication Solutions. The label states each tablet contains Rosuvastatin calcium USP equivalent to Rosuvastatin 20 mg. Storage instructions specify 68 to 77 degrees Fahrenheit and protection from moisture. The package contains 30 tablets.*

FDA Label Image

Figure (Rosuvastatin Fig1)

A box plot chart illustrating percent change from baseline in LDL-C levels for four statins: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin across various doses (10, 20, 40, and for some, 80 mg). The y-axis shows percent change ranging from 0 to -75%, with each drug's dose groups represented by box plots indicating variability in LDL-C reduction.*

FDA Label Image

Figure 2 (Rosuvastatin Fig2)

A cumulative incidence graph comparing Rosuvastatin Calcium (Rosuva) and placebo groups over approximately 5 years. The y-axis shows cumulative incidence percentage, and the x-axis shows time in years. The graph includes hazard ratio (HR 0.56, 95% CI 0.46-0.69) and p-value (<0.001) indicating statistical analysis. Number at risk counts are listed below the x-axis for both groups at various time points.*

FDA Label Image

Figure 3 (Rosuvastatin Fig3)

A forest plot showing hazard ratios and 95% confidence intervals for various cardiovascular endpoints comparing Rosuvastatin Calcium 20 mg to placebo. The endpoints include primary endpoint (major cardiovascular events), cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization, with hazard ratios and p-values listed for each.*

FDA Label Image

Chemical Structure (Rosuvastatin Str)

Chemical structure of Rosuvastatin Calcium showing the molecular arrangement including fluorophenyl, sulfonamide, hydroxy, and carboxylate groups, complexed with calcium ions (Ca2+).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.